Cargando…

Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents

Detalles Bibliográficos
Autores principales: Sharp, Michelle, Donnelly, Seamas C., Moller, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559733/
https://www.ncbi.nlm.nih.gov/pubmed/31187094
http://dx.doi.org/10.1016/j.yrmex.2019.100004
_version_ 1783425853462413312
author Sharp, Michelle
Donnelly, Seamas C.
Moller, David R.
author_facet Sharp, Michelle
Donnelly, Seamas C.
Moller, David R.
author_sort Sharp, Michelle
collection PubMed
description
format Online
Article
Text
id pubmed-6559733
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-65597332019-06-11 Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents Sharp, Michelle Donnelly, Seamas C. Moller, David R. Respir Med X Article 2019-02-21 2019 /pmc/articles/PMC6559733/ /pubmed/31187094 http://dx.doi.org/10.1016/j.yrmex.2019.100004 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license.
spellingShingle Article
Sharp, Michelle
Donnelly, Seamas C.
Moller, David R.
Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title_full Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title_fullStr Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title_full_unstemmed Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title_short Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
title_sort tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-tnf agents
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559733/
https://www.ncbi.nlm.nih.gov/pubmed/31187094
http://dx.doi.org/10.1016/j.yrmex.2019.100004
work_keys_str_mv AT sharpmichelle tocilizumabinsarcoidosispatientsfailingsteroidsparingtherapiesandantitnfagents
AT donnellyseamasc tocilizumabinsarcoidosispatientsfailingsteroidsparingtherapiesandantitnfagents
AT mollerdavidr tocilizumabinsarcoidosispatientsfailingsteroidsparingtherapiesandantitnfagents